Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA81815
Max Phase: Preclinical
Molecular Formula: C34H34FN3O6
Molecular Weight: 599.66
Molecule Type: Small molecule
Associated Items:
ID: ALA81815
Max Phase: Preclinical
Molecular Formula: C34H34FN3O6
Molecular Weight: 599.66
Molecule Type: Small molecule
Associated Items:
Synonyms (2): TCMDC-131853 | TCMDC-131853
Synonyms from Alternative Forms(2):
Canonical SMILES: COc1cc(OCCCN(C)Cc2ccc(OC)c(OC)c2)ccc1NC(=O)c1cccc2c(O)c3cccc(F)c3nc12
Standard InChI: InChI=1S/C34H34FN3O6/c1-38(20-21-12-15-28(41-2)30(18-21)43-4)16-7-17-44-22-13-14-27(29(19-22)42-3)36-34(40)25-10-5-8-23-31(25)37-32-24(33(23)39)9-6-11-26(32)35/h5-6,8-15,18-19H,7,16-17,20H2,1-4H3,(H,36,40)(H,37,39)
Standard InChI Key: ZCWJIRCDTQUXJH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 599.66 | Molecular Weight (Monoisotopic): 599.2432 | AlogP: 6.41 | #Rotatable Bonds: 12 |
Polar Surface Area: 102.38 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 7.93 | CX Basic pKa: 8.70 | CX LogP: 4.79 | CX LogD: 4.46 |
Aromatic Rings: 5 | Heavy Atoms: 44 | QED Weighted: 0.13 | Np Likeness Score: -1.12 |
1. Dodic N, Dumaitre B, Daugan A, Pianetti P.. (1995) Synthesis and activity against multidrug resistance in Chinese hamster ovary cells of new acridone-4-carboxamides., 38 (13): [PMID:7608906] [10.1021/jm00013a017] |
2. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF.. (2010) Thousands of chemical starting points for antimalarial lead identification., 465 (7296): [PMID:20485427] [10.1038/nature09107] |
3. St. Jude Leishmania screening dataset., [10.6019/CHEMBL3433997] |
Source(3):